Evidence map›Paper›PMID 27883036›Full record

ArticleScientific reports2016

The mevalonate pathway regulates primitive streak formation via protein farnesylation.

Yoshimi Okamoto-Uchida, Ruoxing Yu, Norio Miyamura, Norie Arima, Mari Ishigami-Yuasa, Hiroyuki Kagechika, Suguru Yoshida, Takamitsu Hosoya, Makiko Nawa, Takeshi Kasama and 7 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. NIPBLScientific reports · 2018
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 2 countries.

Yoshimi Okamoto-UchidaDepartment of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
Ruoxing YuDepartment of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
Norio MiyamuraDepartment of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
Norie ArimaDepartment of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
Mari Ishigami-YuasaChemical Biology Screening Center, Institute of Biomaterials and Bioengineering, TMDU, Tokyo, Japan.
Hiroyuki KagechikaChemical Biology Screening Center, Institute of Biomaterials and Bioengineering, TMDU, Tokyo, Japan.
Suguru YoshidaDepartment of Chemical Bioscience, Institute of Biomaterials and Bioengineering, TMDU, Tokyo, Japan.
Takamitsu HosoyaDepartment of Chemical Bioscience, Institute of Biomaterials and Bioengineering, TMDU, Tokyo, Japan.
Makiko NawaLaboratory of Cytometry and Proteome Research, TMDU, Tokyo, Japan.
Takeshi KasamaInstrumental Analysis Research Division, Research Center for Medical and Dental Sciences, TMDU, Tokyo, Japan.
Yoichi AsaokaDepartment of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
Reiner Wimmer AloisIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Ulrich EllingIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Josef M PenningerIMBA, Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria.
Sachiko NishinaDepartment of Ophthalmology and Laboratory for Visual Science, National Center for Child Health and Development, Tokyo, Japan.
Noriyuki AzumaDepartment of Ophthalmology and Laboratory for Visual Science, National Center for Child Health and Development, Tokyo, Japan.
Hiroshi NishinaDepartment of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University (TMDU), 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan.
Tokyo Medical and Dental University · JPThe University of Tokyo · JPAustrian Academy of Sciences · ATNational Center For Child Health and Development · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The primitive streak in peri-implantation embryos forms the mesoderm and endoderm and controls cell differentiation. The metabolic cues regulating primitive streak formation remain largely unknown. Here we utilised a mouse embryonic stem (ES) cell differentiation system and a library of well-characterised drugs to identify these metabolic factors. We found that statins, which inhibit the mevalonate metabolic pathway, suppressed primitive streak formation in vitro and in vivo. Using metabolomics and pharmacologic approaches we identified the downstream signalling pathway of mevalonate and revealed that primitive streak formation requires protein farnesylation but not cholesterol synthesis. A tagging-via-substrate approach revealed that nuclear lamin B1 and small G proteins were farnesylated in embryoid bodies and important for primitive streak gene expression. In conclusion, protein farnesylation driven by the mevalonate pathway is a metabolic cue essential for primitive streak formation.

Indexed as

Metabolic Networks and PathwaysProtein PrenylationAnimalsCell DifferentiationDown-RegulationEmbryoid BodiesGene Expression Regulation, DevelopmentalMetabolomeMetabolomicsMevalonic AcidMice, Inbred ICRMyocytes, CardiacNeurogenesisOligonucleotide Array Sequence AnalysisOrganogenesisPrimitive StreakMevalonic Acid

Identifiers

PMID27883036
PMCPMC5121603
OpenAlexW2552674568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.